Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

293
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
293
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

94
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
94
Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

64
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
64
Prediction Intervals01:03

Prediction Intervals

2.3K
The interval estimate of any variable is known as the prediction interval. It helps decide if a point estimate is dependable.
However, the point estimate is most likely not the exact value of the population parameter, but close to it. After calculating point estimates, we construct interval estimates, called confidence intervals or prediction intervals. This prediction interval comprises a range of values unlike the point estimate and is a better predictor of the observed sample value, y. 
2.3K
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

96
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
96

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Exercise-associated changes in leptin and irisin relate to cognitive function in older adults stratified by cognitive impairment.

Scientific reports·2026
Same author

Computed Tomographic Features of a Histopathologically Confirmed Nasal Dermoid Sinus in a Dog.

Veterinary radiology & ultrasound : the official journal of the American College of Veterinary Radiology and the International Veterinary Radiology Association·2026
Same author

How does AI perform compared to human expert panels in medical Delphi studies? A pilot study through the lens of pathology.

Journal of pathology informatics·2026
Same author

Machine Learning Model Predicts Monoclonal Gammopathy Using Routine Laboratory Values.

JCO clinical cancer informatics·2026
Same author

Foreign Comparator Drug Products, Manufacturing & Supply Chain Considerations for Otic, Ophthalmic, And Parenteral Solutions - Generic Drugs Perspective.

The AAPS journal·2026
Same author

Comment on "Adopting Race-Free Estimated Glomerular Filtration Rate for Unifying Medication-Related Decision-Making: An Opinion of the Nephrology Practice and Research Network of the American College of Clinical Pharmacy".

Journal of the American College of Clinical Pharmacy : JACCP·2026

Related Experiment Video

Updated: Jul 18, 2025

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

7.1K

CKD Progression Prediction in a Diverse US Population: A Machine-Learning Model.

Joseph Aoki1, Cihan Kaya1, Omar Khalid1

  • 1Sonic Healthcare USA.

Kidney Medicine
|August 28, 2023
PubMed
Summary

A new machine learning model accurately predicts chronic kidney disease (CKD) progression using common lab results. This tool aids early detection and management of kidney disease, improving patient outcomes.

More Related Videos

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.6K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.1K

Related Experiment Videos

Last Updated: Jul 18, 2025

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

7.1K
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.6K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.1K

Area of Science:

  • Nephrology
  • Data Science
  • Biostatistics

Background:

  • Chronic kidney disease (CKD) is a significant global health issue associated with high morbidity and mortality.
  • Predictive models for CKD progression are lacking, especially for early disease stages.
  • Early identification of CKD progression is crucial for timely intervention and management.

Purpose of the Study:

  • To develop and validate machine learning models for predicting CKD progression using readily available demographic and laboratory data.
  • To assess the performance of these models across the spectrum of CKD.
  • To identify key predictors of accelerated kidney function decline.

Main Methods:

  • A retrospective observational study utilizing deidentified laboratory data from 110,264 adult patients over 5 years.
  • Machine learning models, specifically random forest survival methods, were employed.
  • Predictors included demographic and laboratory characteristics, with a focus on estimated glomerular filtration rate (eGFR) slope and urine albumin-creatinine ratio.

Main Results:

  • A 7-variable risk classifier achieved an area under the curve (AUC) of 0.85 for predicting >30% eGFR decline within 5 years.
  • The most significant predictor of CKD progression was the eGFR slope.
  • Other key predictors included initial eGFR, urine albumin-creatinine ratio, serum albumin (initial and slope), age, and sex.

Conclusions:

  • The developed machine learning classifier accurately predicts significant eGFR decline in patients with CKD.
  • The model effectively utilizes easily obtainable laboratory data for risk prediction.
  • This tool has the potential to enhance early recognition and optimize management strategies for patients at risk of CKD progression.